Daily BriefsHealthcare

Daily Brief Health Care: Otsuka Holdings and more

In today’s briefing:

  • Otsuka Holdings (4578 JP): Guidance Revised Upward for 2024, Core 2 Products Show Strength


Otsuka Holdings (4578 JP): Guidance Revised Upward for 2024, Core 2 Products Show Strength

By Tina Banerjee

  • Otsuka Holdings (4578 JP) has revised revenue guidance for 2024 to ¥2,320B from previous ¥2,310B. Pharmaceutical business and nutraceutical business performed strongly.
  • 2024 operating profit guidance have been revised slightly upwards to ¥323B. Due to the impact of temporary tax adjustment in U.S., net profit guidance raised by 43% to ¥343B.
  • Otsuka shares have rallied 40% in the last one year. With multiple growth drivers at play Otsuka is poised for accelerated growth.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars